← Scroll for more →
Financial Statements — HCAI
Balance Sheet
(in millions USD)| Metric | Q4 2025 | Q2 2025 | Q4 2024 |
|---|---|---|---|
| Cash & Equivalents | 0.00 | 0.05 | 0.03 |
| Accounts Receivable | 7.07 | 30.41 | 19.50 |
| Inventory | -- | 3.58 | 1.43 |
| Total Current Assets | 11.95 | 46.64 | 34.67 |
| Property, Plant & Equipment | -- | 8.61 | 8.90 |
| Intangible Assets | -- | 0.06 | 0.01 |
| Total Non-current Assets | 0.04 | 10.94 | 11.19 |
| Total Assets | 11.99 | 57.58 | 45.85 |
| Accounts Payable | -- | 5.55 | 2.68 |
| Short-term Debt | -- | 3.51 | 3.35 |
| Total Current Liabilities | 6.77 | 17.17 | 13.43 |
| Total Non-current Liabilities | 0.02 | 4.48 | 4.58 |
| Total Liabilities | 6.79 | 21.65 | 18.01 |
| Retained Earnings | (25.04) | 17.69 | 16.87 |
| Total Stockholder Equity | 5.20 | 23.46 | 15.81 |
← Scroll for more columns →
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2025 |
|---|---|
| Total Revenue | 8.15 |
| Cost of Revenue | 5.58 |
| Gross Profit | 2.57 |
| Research & Development | 0.04 |
| Selling, General & Admin | 1.25 |
| Total Operating Expenses | 1.29 |
| Operating Income | 1.28 |
| Pretax Income | 1.25 |
| Tax Provision | 0.00 |
| Net Income | 0.82 |
| Basic EPS | 0.04 |
| Diluted EPS | 0.04 |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2025 |
|---|---|
| Operating Cash Flow | (5.45) |
| Capital Expenditures | 0.00 |
| Free Cash Flow* | (5.46) |
| Investing Cash Flow | -0.00 |
| Financing Cash Flow | 4.66 |
← Scroll for more columns →
* Derived from reported values